Researchers require technology to store, transfer, and process biological data accurately and quickly to make drug discovery more efficient.
Researchers require technology to store, transfer, and process biological data accurately and quickly to make drug discovery more efficient. Deep Genomics, a leading artificial intelligence (AI) therapeutics company based in Toronto, has attractedapproximately US $224M in funding for its AI workbench that can decode biology to program life-changing medicines.